Sponsor Pipeline

Amicus Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
4
Phase 3
Active Trials by Phase
Phase 3
4
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04808505 A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase… Glycogen Storage Disease Type II Infantile Onset Recruiting
NCT06904261 A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and… Fabry Disease Recruiting
NCT03911505 ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in… Pompe Disease (Late-onset) Active, Not Recruiting
NCT04020055 A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal… Fabry Disease Active, Not Recruiting
Not specified
NCT04252066 A Global Prospective Observational Study of Women With Fabry Disease and Their Infants… Fabry Disease Recruiting
NCT06121011 A Global Prospective Observational Registry of Patients With Pompe Disease Pompe Disease Recruiting
NCT06906367 A Study of Patients With Fabry Disease (US Specific) Fabry Disease Recruiting
Get alerts when Amicus Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free